Court Denies Novo's Attempt to Halt Lilly's Obesity Drug Advertising | Retatrutide News

A judge ruled against Novo Nordisk's effort to block Eli Lilly's obesity drug ads, citing lack of proven sales harm. This decision affects the competiti...
Market News · October 28, 2026